NICE evidence standards framework for digital care technologies
NICE adapts its evidence standards framework for digital health technologies to support decision-making for digital care technologies in adult social care.
UK NICE · UK
Source
UK NICE
UK NICE is an official public source that HealthSignal monitors for Market Access & Reimbursement, Digital Health & AI, General Regulatory. The most recent updates we have tracked from it are listed below, each normalised into our index and linked back to the original publication on the source's own website.
Regulation
Category
Type · Breadth
Date
NICE consultation: adoption of the new EQ-5D-5L value set
NICE invites input on adopting a new EQ-5D-5L value set to improve health-related quality-of-life assessments in treatment evaluation.
UK NICE · UKIn-situ abdominal normothermic regional perfusion for donor liver preservation recommended for NHS use
NICE recommends in-situ abdominal normothermic regional perfusion as an option to preserve donor livers before transplantation.
UK NICE · UKNICE guidance: artificial pancreas technology for pregnant women with type 1 diabetes
NICE recommends offering pregnancy-specific artificial pancreas devices to women with type 1 diabetes who are pregnant or planning pregnancy.
UK NICE · UKNew age-based blood test thresholds recommended by NICE for earlier ovarian cancer diagnosis
NICE recommends replacing one-size-fits-all blood test thresholds with personalised, age-based criteria to improve early ovarian cancer detection in primary care.
UK NICE · UKOnline help programme recommended for people with eating disorders
NICE recommends an online therapy programme for people aged 16 and over with eating disorders awaiting specialist NHS treatment.
UK NICE · UKNICE conditional recommendation: AI tools for bowel cancer detection during colonoscopy
NICE conditionally recommends five AI technologies as decision-support tools during bowel examinations to improve early detection of precancerous growths.
UK NICE · UKHarnessing the potential of AI to bring real benefits for patients
Artificial intelligence has huge potential to improve health and care, but its use must be safe, effective and fair. In this blog, chief executive Jonathan Benger explains how NICE's new AI delivery plan will support ...
UK NICE · UKNICE draft guideline for PMOS (polycystic ovary syndrome): public consultation
NICE has issued a draft guideline for PMOS (formerly PCOS) for public consultation until 11 August 2026.
UK NICE · UKNeonatal infection guidance updated to allow home antibiotic treatment for some babies
NICE recommends newborns responding well to hospital antibiotics may switch to oral antibiotics and receive care at home.
UK NICE · UKNew sepsis guideline targets faster, tailored treatments to benefit patients
NICE published updated guidance on sepsis treatment for patients aged 16 or over, recommending more tailored treatment approaches.
UK NICE · UKNICE guideline on kidney cancer: better use of biopsies to avoid surgery
New guidance recommends improved use of biopsies in kidney cancer diagnosis to reduce unnecessary surgery and treatment variation.
UK NICE · UKNICE draft guideline on polyendocrine metabolic ovarian syndrome (PMOS): annual review and diagnosis
NICE invites consultation on draft guidance recommending annual review and earlier diagnosis of PMOS to monitor symptoms, treatment and long-term health risks.
UK NICE · UKGetting ahead of heart failure, 1 alert at a time
Remote monitoring approach for heart failure patients reduced unnecessary hospital admissions by 58% and saved £4,158 per patient.
UK NICE · UKNICE recommends new dedicated fertility treatment pathway for endometriosis
NICE updated its fertility guideline to include a new section on fertility treatment pathways specifically for people with endometriosis.
UK NICE · UKNICE publishes first quality standard to improve care for people with rare diseases
NICE published its first quality standard on rare diseases, developed in partnership with an external organisation.
UK NICE · UKNICE annual report and accounts 2025 to 2026
Our annual report and accounts covering April 2025 to March 2026 highlight our key achievements. Find out how we’re delivering against the 10 Year Health plan, and how we’re becoming more relevant, timely, impactful a...
UK NICE · UKHow the faecal immunochemical test is changing bowel cancer referrals and what it tells us about the power of NICE guidance
NICE guidance on faecal immunochemical testing for bowel cancer has reduced unnecessary urgent referrals by 140,000 annually while maintaining cancer detection rates.
UK NICE · UKModern Service Frameworks: raising the standards of care
Modern Service Frameworks aim to make high-quality care more consistent across England. Deputy chief medical officer, Judith Richardson explains how NICE guidance is helping turn evidence into practical service improv...
UK NICE · UKBetter data for better decisions
NICE publishes EQ-5D-5L value set to support health technology assessment and NHS reimbursement decisions.
UK NICE · UKXVIVO Perfusion System for lung preservation: conditional NICE recommendation
NICE conditionally recommends the XVIVO Perfusion System for lung preservation outside the body for 4 years while evidence is generated.
UK NICE · UKPatients to get new medicines up to six months sooner under new joint MHRA-NICE approval process
MHRA and NICE are launching a streamlined approval process to deliver new medicines to patients 3 to 6 months earlier.
UK NICE · UKNICE: Reviewing 2025 — producing faster rigorous guidance to make an impact on patients' lives
We look back on the guidance we've produced in 2025. Podcasts 17 December 2025
UK NICE · UKThe device that raised the alarm and saved my life
Patient testimonial on heart failure remote monitoring device recommended by NICE in clinical trial.
UK NICE · UKNICE Talks: Endometriosis fertility care and gynaecological cancer guidance
In this episode of NICE Talks, we're covering some of the most significant guidance updates of the year so far for women's health and cancer care. Podcasts 01 May 2026
UK NICE · UKNICE recommends teplizumab for NHS use to delay type 1 diabetes onset
NICE has recommended teplizumab for NHS use as the first treatment to delay symptomatic type 1 diabetes onset by approximately three years.
UK NICE · UKNICE approval: aficamten (Myqorzo) for obstructive hypertrophic cardiomyopathy
NICE recommends funding aficamten for around 6,600 people in England with obstructive hypertrophic cardiomyopathy following MHRA authorisation.
UK NICE · UKNICE recommends acalabrutinib for mantle cell lymphoma and chronic lymphocytic leukaemia
NICE recommends acalabrutinib in combination with bendamustine and rituximab for newly diagnosed mantle cell lymphoma and chronic lymphocytic leukaemia.
UK NICE · UKNICE recommendation: finerenone for chronic heart failure with preserved or mildly reduced ejection fraction
NICE recommends finerenone for adults with chronic heart failure with preserved or mildly reduced ejection fraction in England.
UK NICE · UKNew treatment option recommended for recurrent or metastatic cervical cancer
NICE recommends a new treatment for recurrent or metastatic cervical cancer for NHS funding.
UK NICE · UKFrom £1 to £180: how NICE guidance helped us make smarter slide sheet choices
Learn how our evidence-based guidance helped a London NHS trust standardise procurement and generate operational efficiencies.
UK NICE · UKNICE approval: innovative COPD treatment reducing flare-ups
NICE has approved an innovative therapy for COPD that reduces flare-ups by approximately one-third.
UK NICE · UKBreakthrough life-extending combination treatment for advanced bladder cancer recommended by NICE
NICE recommends a new combination treatment for advanced urothelial cancer, with clinical trials showing almost double overall survival versus standard treatment.
UK NICE · UKNICE final guidance: cerliponase alfa (Brineura) not recommended for routine NHS use in CLN2 Batten disease
NICE has issued final guidance declining to recommend cerliponase alfa for routine NHS treatment of neuronal ceroid lipofuscinosis type 2.
UK NICE · UKNICE recommendation: rozanolixizumab for uncontrolled generalised myasthenia gravis
NICE recommends rozanolixizumab for adults with generalised myasthenia gravis uncontrolled by existing treatments.
UK NICE · UKNICE approves bevacizumab biosimilars for advanced bowel cancer
NICE has approved bevacizumab biosimilars for reimbursement in England for advanced bowel cancer treatment.
UK NICE · UKNICE recommends new life-extending drug combination for advanced prostate cancer
NICE recommends a new treatment combination for metastatic prostate cancer, enabling access in England from 24 October.
UK NICE · UKHow NICE guidance is accelerating access to innovative migraine treatments
In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. Podcasts 26 February 2026
UK NICE · UK
Showing 38 of 38 tracked updates
Health-tech only